CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 182 enrolled
Drug / intervention
Systemic Dexamethasone +1 moredrug
Likely dose
Systemic Dexamethasone 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02322242
NCT02322242Phase 4Completed

Comparison of the Effects of Perineural Versus Systemic Dexamethasone on Low Dose Interscalene Brachial Plexus Block: A Randomized Control Trial

Dr. Stephen Choi·interventional·Posted Dec 23, 2014·Updated Jul 15, 2020

In Brief

A Phase 4 clinical trial evaluating Systemic Dexamethasone and Perineural dexamethasone for Shoulder Surgery and Nerve Block. Completed, enrolled 182 participants across 1 site.

Detailed Summary

A standard interscalene nerve block is performed with long acting local anesthetic (bupivacaine or ropivacaine in concentrations varying from 0.25% to 0.75%). The purpose of this study is to investigate the effect of the addition of perineural dexamethasone (4mg) to a standard ropivacaine solution (0.5%) on analgesic duration of low dose interscalene block compared to ropivacaine alone for interscalene block with systemic dexamethasone. Ropivacaine is not an intervention as a local anesthetic is pre-requisite to performing a nerve block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 23, 2014
Enrollment StartJan 1, 2015
Primary CompletionJan 1, 2019
Study CompletionMay 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 11.5 years ago

Interventions

Systemic Dexamethasonedrug

Intravenous infusion of dexamethasone (4mg)

Perineural dexamethasonedrug

Perinerual administration of dexamethasone (4mg)